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Abstract
Background: In dogs, increasing the tissue n-3 fatty acid (FA) content is associated with potential benefit in some
medical conditions, e.g. atopic dermatitis, cancer or heart disease. Therefore effectively and conveniently increasing
tissue n-3 FA levels in dogs is of interest. Incorporation of dietary n-3 FA into cell membranes may be studied by
FA analysis of erythrocyte membranes (EM), because of the correlation of its FA composition with the FA
composition of other cells. Aim of the study was to determine whether an n-3 FA additive added to a control diet
is as effective in increasing EM n-3 FA content as feeding an n-3 FA enriched diet. Furthermore the time course of
the incorporation of dietary n-3 FA into canine EM was investigated.
Methods: Thirty dogs were randomly divided into three dietary groups with ten dogs per group. CONT got a dry
dog food diet which did not contain EPA or DHA. FO got a dry dog food diet with a high EPA and DHA content.
ADD got the CONT diet combined with an n-3 FA additive rich in DHA and EPA. After a feeding period of 12
weeks the additive was discontinued in ADD and these dogs were fed CONT diet for another four weeks to
observe washout effects. Erythrocyte lipids were extracted from venous blood samples and their FA composition
was determined by gas chromatography. The Mann-Whitney-U-test was used to detect significant differences
between the different groups and time points.
Results: After one week the proportions of n-3 FA, DHA and EPA were already significantly increased in ADD and
FO, apparently reaching a plateau within eight weeks. In our study DHA and not EPA was preferably incorporated
into the EM. After discontinuing the administration of the additive in ADD, the n-3 FA values declined slowly
without reaching baseline levels within four weeks.
Conclusions: In dogs, an increase of dietary n-3 FA content leads to a rapid inclusion of n-3 FA into EM, regardless
of whether the n-3 FA are offered as an enriched diet or as a normal diet supplemented with an n-3 FA additive.
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Background
Polyunsaturated fatty acids (PUFA) such as arachidonic
acid (AA), docosahexaenoic acid (DHA), eicosapentae-
noic acid (EPA), and linoleic acid (LA), which are pre-
sent in cell membrane lipids, are important for many
biochemical and physiological functions[1]. The
proportion of the different types of fatty acids (FA) in
the cell membrane influences the properties of the
membranes[2] and the release of inflammatory media-
tors[3]. The mechanism likely to be responsible for the
potential benefits of n-3 FA in inflammatory diseases is
that the eicosanoids produced from the breakdown of
n-3 FA are less potent inflammatory mediators than
those produced from n-6 FA[3]. Therefore, increasing
the dietary level of n-3 PUFA has the potential to pre-
vent or treat a variety of medical conditions in humans
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any medium, provided the original work is properly cited.and animals, e.g. arthritis, some cancers, cardiovascular
disease, depression or neurological diseases[4]. Also in
dogs, the consumption of n-3 PUFA has been linked to
beneficial effects on atopic dermatitis[5], cancer[6], heart
disease[7] and chronic renal failure[8].
Among the n-3 FA EPA and DHA are generally con-
sidered to be the FA that have the most beneficial
effects. Controversy exists about which n-3 fatty acid is
responsible for the main effect of n-3 FA supplementa-
tion. Although dual supplementation with both EPA
and DHA was found to have beneficial effects, there
have been some studies in rodents suggesting that for a
certain disease one n-3 FA might be more beneficial
than the other. One study comparing the anti-inflamma-
tory effects of DHA and EPA in induced contact derma-
titis in mice determined that although both EPA and
DHA can ameliorate dermatitis, EPA appears to be
more potent[9]. In another study with an induced mam-
mary tumor model in rats, DHA was found to be more
effective than EPA in suppressing mammary carcinogen-
esis[10]. In human medicine, the inclusion of plentiful
DHA in the diet is considered to improve learning abil-
ity and the development of theb r a i n [ 1 1 ] .I ft h e s ef i n d -
i n g sa r ev e r i f i e di nd o g s ,t h ea b i l i t yt os e l e c t i v e l y
increase the incorporation of either DHA or EPA into
cell membranes according to the therapeutic goal,
would be desirable as part of the disease management.
Fish and fish oils are rich in long chain n-3 FA, mostly
EPA and DHA[12], whereas terrestrial plants only pro-
vide alpha linolenic acid (ALA) [13]. Although ALA can
be converted to EPA, which can then be elongated to
DHA, in dogs the conversion of ALA to EPA is less effi-
cacious than providing dietary EPA. For DHA this effect
is even more pronounced than for EPA, since the con-
version rate is even lower[14]. Therefore increasing tis-
sue EPA and especially DHA levels via dietary
manipulation would be of interest for the diseased dog.
Since a complete change of the diet is not always possi-
ble in dogs requiring a certain diet due to health pro-
blems or might not be acceptable to the dog owner, we
sought to determine if supplementing a diet that is low
in n-3 FA with an n-3 FA additive is as effective in
increasing membrane n-3 FA content and especially
membrane EPA and DHA content. When using dietary
intervention in a clinical setting it would also be of
interest to know when and to which extent changes in
the fatty acid composition of the cell membranes can be
expected.
T h ee r y t h r o c y t em e m b r a n e( E M )i so n eo ft h ep r o t o -
types of cell membrane that has been extensively studied
as a model because of its ready availability[2]. Since FA
composition of the EM correlates with that of other cell
membranes, the effect of dietary FA supplementation
may be studied by FA analyses of EM[1,15]. In previous
studies, significant correlations have been found between
PUFA intake and incorporation of PUFA into erythro-
cyte membranes[16]. Thus, monitoring incorporation of
n-3 FA into EM is a suitable model for monitoring the
FA intake[17].
The aim of the study was to determine whether an n-
3 FA additive added to a control diet not containing any
EPA or DHA, is as effective in increasing membrane n-3
FA content as a complete change of the diet to an n-3
FA enriched diet. Furthermore we sought to investigate
t h et i m ec o u r s eo ft h ei n c o r p o r a t i o no fd i e t a r yn - 3F A
into canine EM using an n-3 FA supplemented diet and
an n-3 FA enriched diet in comparison with a control
diet.
Materials and methods
Animals
Thirty clinically healthy, intact Beagle dogs (fifteen male,
fifteen female; mean age of 2.2 ± 0.65 years) were cho-
sen for the present study. The dogs were pair-housed in
kennels and fed individually. Individual weights were
taken at the beginning of the study and the amounts of
dog food were rationed according to the recommenda-
tions of the manufacturer of the diets (g food per kg
body weight). Water was provided ad libitum all day.
The study was carried out at Summit Ridge Farms, Sus-
quehanna, PA, USA. Experiments were approved by the
Institutional Animal Care and Use Committee and con-
ducted in accordance to the principles and specific
guidelines presented in the Guide for the Care and Use
of Laboratory Animals published by the US National
Institute of Health.
For eight weeks up to the onset of the study the dogs
were fed with a dry dog food diet (Joy Special Meal, Joy
Pet Foods, St. Marys, Ohio, USA) that does not contain
any PUFA from fish oil. This diet served as a control
diet during the 12 week study period. The dogs were
fed once a day at 8 am. Individual food intake was
determined daily by weighing the individual feeding
bowls before and after feeding.
Experimental Design
The study was a prospective open label, randomised
study. Prior to the onset of the study, the included dogs
were randomly assigned to three groups with ten dogs
per group (five males; five females). Dogs in the control
g r o u p( C O N T )w e r ef e d3 0 0go ft h ec o n t r o ld i e t ,d o g s
in the FA diet group (FO) were fed 250 g of a commer-
cial dog food (Eukanuba
® Medium Breed Puppy) con-
taining fish oil (FO) and dogs in the additive (ADD)
group were fed 300 g of the control diet supplemented
by syringe with 0.09 ml (= 85 mg) per kg of body weight
of a fish oil concentrate (Refortin
®,a c c o r d i n gt ot h e
manufacturers’ recommendations). All diets were given
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group got the control diet without the additive for
another 4 weeks to observe washout effects. The n-3 FA
additive used had an energy content of 38.0 KJ/g and
contained 14% EPA and 48% DHA. The analytical com-
position and FA patterns of the diets are listed in Table
1 .A n a l y s i so ft h ed i e t sw a sd o n eb yE u r o f i n sS t e i n s
laboratory A/S, Vejen, Denmark.
Blood samples were taken by jugular vein puncture six
hours after feeding at week 0, 1, 2, 4, 8 and 12, and
additionally at week 14 and 16 for ADD. EDTA was
used as anticoagulant. After sampling syringes with
blood were immediately put on ice. The health of all
dogs was monitored by routine clinical examinations.
Measurements and analyses
Immediately after blood sampling erythrocyte ghosts
were prepared as described previously[18,19]. Blood
samples were centrifuged at 4°C for 5 minutes at 865 g
and the plasma was aspirated. Erythrocytes were washed
t h r e et i m e si na5 - f o l dv o l u m eo fc o l ds a l i n e( p H=7 . 4 )
with subsequent centrifugation at 4°C for 5 minutes at
2862 g. Leukocytes and saline were aspirated after each
washing. The remaining erythrocyte pellet was lysed in
5 mM phosphate buffer (volume ratio: 1:7). The lysed
erythrocytes were kept frozen at -80°C until lyophilisa-
tion. The dried pellets were weighed and kept frozen
until further use (-80°C).
Total erythrocyte lipids were extracted with hexane
and transmethylated with methanolic HCl containing
0.2% butylhydroxytoluol as antioxidant[20]. FA concen-
trations were analysed by measuring fatty acid methyl
esters via gas chromatography with di-C17-phosphati-
dylcholine as internal standard, as previously described
[18,21]. Methyl esters were measured with a Varian CP
3800 gas chromatograph (Varian, Darmstadt, Germany)
equipped with a flame ionization detector. The chro-
matogram was analysed by means of the program Star
5.5 (Varian), with the internal standard as reference
peak. In total 44 FA were determined. For the calcula-
tion of total n-3 and total n-6 FA in the diet the sum
of all n-3 and n-6 FA analysed by Eurofins Steins
laboratory A/S, Vejen, Denmark, with a chain length
between 18 and 22 carbon atoms was calculated,
namely C 18:3n3 (ALA), C 18:4n3, C 20:4n3, C 20:5n3
(EPA), C 22:5n3 (docosapentaenoic acid, DPA) and C
22:6n3 (DHA) for calculation of total n-3 FA and C
18:2n6 (LA), C 18:3n6, C 20:2n6, C 20:4n6 (AA), C
22:4n6 and C 22:5n6 for calculation of total n-6 FA. In
EM, we were additionally able to detect small amounts
of the n-3 FA C 20:3n3 and C 22:4n3 and of the n-6
FA C 20:3n6 and C 22:2n6, which were also used for
the calculation of the total amount of n-3 and n-6 FA
of EM, respectively. The fatty acids that were included
in the calculated amount of total n-7, n-9 and satu-
rated fatty acids in the diets and in EM are listed in
additional file 1. The FA pattern calculated on a molar
base is given in %. Areas under the curves (AUC) of
the percentage of EPA and DHA in EM over the 12
weeks of the study period were calculated by the soft-
ware SigmaPlot (version 11, Systat Software, Erkrath,
Germany) in order to determine the response to FA
administration over time.
Statistical Analyses
Since the Levene test for homogeneity of variances
showed significant differences within the study period
for some FA, we decided to use nonparametric tests for
all FA and groups. Hence, data were expressed as med-
ian (± quartile). For the FA of interest the Kruskal-
Wallis test was performed. For those that showed statis-
tically significant differences over time the Mann-Whit-
ney-U-Test was computed for comparison of the
individual time points within the group. The same test
was used for comparison between groups at the differ-
ent time points. Statistical analysis was conducted with
PASW (version 18, SPSS Inc., Chicago, IL, US) and a
two-sided p-value ≤ 0.01 was considered to be statisti-
cally significant.
Table 1 Analytical composition of the dog food products
and fatty acid (FA) pattern (%) of dog food
Components Joy special
meal
Eukanuba
® medium breed
puppy
Raw fat 11·0% 18·0%
Crude protein 27·0% 29·0%
Crude fiber 4·0% 4·0%
Moisture 10·0% 8·0%
energy content 14·6 kJ/g 18·0 kJ/g
Fatty acid pattern
FA in g/kg total diet
LA*
1 19·69 35·64
AA†
1 0·25 1·13
ALA‡
2 2·86 1·76
SDA| 0·2 0·16
EPA
2 - 1·66
DHA
2 - 1·1
Total n-3 3·08 5·22
Total n-6 20·35 37·8
Total n-7 FA 5·09 14·33
Total n9 FA 39·8 64·49
Total SFA 38·61 54·0
Ratio total n-6/total
n-3
6·61/1 7·24/1
Data are based on an as fed basis. The FA included for the calculation of total
n-3, total n-6 and total saturated FA are listed in additional file 1.
*LA, linoleic acid; †AA, arachidonic acid; ‡ALA, a-linolenic acid; | SDA,
stearidonic acid;
1 n-6 FA
2 n-3 FA
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Animals
The experimental feeding was well tolerated by all dogs
as appetite was maintained and no clinical signs were
found in routine clinical examinations. The compliance
to the diet was high throughout the study. As the body
weights of the dogs were similar (Table 2) all dogs
within the same group got the same amount of food
and the dose of the additive was also similar among the
dogs of ADD (0.92 ml ± 0.17 ml) during the study per-
iod. As the amount of food in ADD was not corrected
for the energy content supplied by the additive and the
manufacturers’ recommendations were slightly different
between CONT and FO, energy intake in dogs in ADD
and FO was slightly higher than that from dogs in
CONT (0.77% and 2.74%, respectively). However, all
dogs maintained their body weight during the study (±
1.2 kg). The average daily FA consumption per kg body
weight in the three test groups is given in Table 2.
Fatty acid composition of erythrocyte membranes
The FA baseline levels at week 0 did not differ signifi-
cantly among the dietary groups (all p ≥ 0.02). There
were no significant differences in the percentage of n-7,
n-9 and saturated FA between the groups at any time
point except for week 12 when the content of total n-7
FA was significantly higher in FO than in ADD (p ≤
0.01). Likewise, there were very few statistically signifi-
cant differences in the proportion of n-7, n-9 and
saturated FA in CONT, ADD and FO between the dif-
ferent time points within the respective group (all p ≤
0.01) (additional file 2).
Erythrocyte n-3 FA content at baseline was 1.5% of
total FA (Figure 1). Both n-3 diets significantly increased
the amount of n-3 FA in EM after the first week (p ≤
0.01), apparently reaching a plateau within eight weeks
(Figure 1). The rise in n-3 FA (mainly EPA and DHA)
in ADD and FO during the feeding period was compen-
sated by a decrease in n-6 FA as shown in Figure 2. In
FO significant reductions in n-6 FA content in compari-
son with the control group could be observed at week 2,
8a n d1 2( a l lp≤ 0.01). In ADD the amount of n-6 FA
did not decrease significantly in comparison with the
control group until week 8 (p ≤ 0.01). In CONT, n-6 FA
were significantly lower at week 12 compared to all
other time points and showed significant differences
between week 2 and 8 (all p ≤ 0.01). Due to the changes
in n-6 and n-3 FA the n-6/n-3-ratio changed from 30/1
(week 1) to 12, 5/1 (week 12) in both ADD and FO.
In ADD, the relative amounts of EPA (Figure 3) and
DHA (Figure 4) in EM increased gradually and signifi-
cantly during supplementation (p ≤ 0.01) and did not
return to their baseline levels within the 4 weeks of the
washout period. During the whole study period the
values of EPA and DHA in EM of ADD and FO differed
significantly from those before supplementation and
from those of CONT (p ≤ 0.01). In ADD, the amount of
EPA in EM reached a plateau within two weeks already,
whereas in FO, it took 4 weeks for EPA to be equili-
brated (Figure 3). According to the different content of
DHA and EPA in ADD and FO the increase of DHA
was more pronounced in ADD (Figure 4), whereas EPA
reached higher values in FO (Figure 3). The percentage
of DHA in EM showed statistically significant differ-
ences between the n-3 dietary groups throughout the
period of feeding (week 1 until week 12) (p ≤ 0.01). The
amount of EPA significantly differed at week 4, 8 and
12 between ADD and FO (p ≤ 0.01). In CONT EPA
showed statistically significant differences at week 12
compared to all other time points (p ≤ 0.01). DHA in
CONT showed significant differences between the first
4 weeks of the study and week 8, whereas there were no
significant differences between week 12 and all other
time points (all p ≥ 0.02).
After an initial increase at week 1 DPA showed a
steady decrease in ADD until week 12. However, statisti-
cally significant differences could only be observed
between week 1 and all time points from week 8 until
the end of the study and between week 2 and 12 (addi-
tional file 3) (p ≤ 0.01). There were no statistically sig-
nificant differences in DPA membrane content in
CONT and FO during the study period (p ≥ 0.77 and p
≥ 0.18, respectively).
Table 2 Age and weight of the dogs (mean ± SD) at
baseline and at week 12 of experimental feeding as well
as daily fatty acid (FA) intake per kg body weight in
control (CONT), additive (ADD) and fish oil (FO) group
CONT ADD FO
Mean SD Mean SD Mean SD
Age (years) 2.2 1 2.1 0.3 2.3 0.5
Weight (kg) week 1 10.9 0.69 10.3 0.65 10.7 0.83
week 12 11.2 0.72 10.5 0.64 11.4 0.84
FA intake
mg/d/kg body weight
LA*
1 483.3 516.1 742.5
AA†
1 6.2 6.6 23.6
ALA‡
2 70.2 75 36.8
SDA| 4.8 5.1 3.6
EPA
2 - 11.9 34.5
DHA
2 - 40.8 22.9
Total n-3 75.6 142.2 108.8
Total n-6 499.5 533.4 787.5
The FA included for the calculation of total n-3 and total n-6 FA are listed in
additional file 1.
*LA, linoleic acid; †AA, arachidonic acid; ‡ALA, a-linolenic acid; | SDA,
stearidonic acid;
1 n-6 FA
2 n-3 FA
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0.01) apparently reaching a plateau at week 8. In ADD
and CONT, there were no significant changes in ALA
content at any point in time (p ≥ 0.94 and p ≥ 0.42,
respectively).
No changes were observed in the percentage of AA in
EM of CONT during the whole study. In ADD and FO,
the median AA proportions (Figure 5) decreased gradu-
ally during supplementation from 29.5%, to the lowest
concentration (26.6%) at week 12 in ADD. Significant
differences between initial values and AA content in EM
of ADD after supplementation were observed from week
8 until the end of the study (p ≤ 0.01). At week 12 the
proportion of erythrocyte AA in ADD differed signifi-
cantly from those of CONT and FO (p ≤ 0.01).
The membrane content of LA did not change signifi-
cantly in any group during the study (all p ≥ 0.01).
The AUC of DHA and EPA in EM (Figure 6)
increased according to the dietary intake of DHA and
EPA. However, the AUC of DHA (ADD: 17.46 (16.83;
19.08) FO: 13.21 (12.08; 13.95)) was higher than that of
EPA (ADD: 7.97 (7.52; 9.63) FO: 11.33 (10.07; 12.05)).
After changing to CONT feeding in ADD (week 12),
the altered FA values declined slowly or increased,
respectively, without reaching baseline levels within the
four weeks of the washout period (Figures 1, 2, 3, 4, 5).
Discussion
We compared the incorporation of n-3 FA into EM in
dogs fed three types of diet; a control diet containing
low amounts of EPA and DHA, the control diet supple-
mented with an n-3 FA additive and a commercial dog
food containing n-3 FA from fish oil. The initial FA pro-
portions of the EM are consistent with previous obser-
vations except for total n-6 FA and AA. These values
(44.5 and 29.5%, respectively) were higher than in a pre-
vious study in rats[16] and much higher than in erythro-
cytes of human subjects consuming no additional n-3
Figure 1 n-3 fatty acids (FA) in erythrocyte membranes in the three different dietary groups. Median and quartiles of the percentage of
n-3 FA in erythrocyte membranes in control (CONT), additive (ADD) and fish oil (FO) group at week 0, 1, 2, 4, 8, 12, 14 and 16 of experimental
feeding. Different uppercase letters indicate statistically significant differences between different time points within the individual groups.
Different Lowercase letters indicate statistically significant differences between groups at the same time point. (p ≤ 0.01). The FA included for the
calculation of total n-3 FA are listed in additional file 1.
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different AA and n-6 FA content in the diets or to spe-
cies specific differences in the FA composition of cell
membranes [19]. In ADD and FO, DHA and EPA in
EM were already elevated after one week. In several stu-
dies it was observed that diets containing different
amounts of n-3 FA led to increased values of these
PUFA in EM[12,22-25]. Our data suggest that this
increase can be achieved with an enriched diet as well
as with a normal diet supplemented with an n-3 FA
additive. To our knowledge no study exists observing
such a rapid change in erythrocyte FA of dogs as in our
study. These results agree with the data of Kew et al.
[26] in mice. In their study, feeding high levels of EPA
or DHA resulted in significantly increased splenocyte
EPA or DHA after one week of supplementation. Our
results are also consistent with the findings of Hansen
et al.[27], in which canine serum EPA and DHA con-
centrations were significantly increased after one week
of fish oil supplementation. In contrast, other
researchers found significant differences to initial values
not before week 2 or later. However, many of these stu-
dies were conducted with other species and started the
first sampling at week 2 or later [12,22-25].
FA could be incorporated into EM during erythropoi-
esis, or by interaction of mature erythrocytes with
plasma FA[28]. In dogs the average lifespan of erythro-
cytes is 17 weeks[29]. Hence, the significant increase of
FA in erythrocytes during the first week of administra-
tion of n-3 PUFA we observed in our study cannot be
explained by entry of new erythrocytes into the circula-
tion[25], but indicates a rapid exchange between ery-
throcyte and plasma FA. The exchange of FA between
plasma and blood cells may occur by different routes, e.
g. the transfer of albumin-bound nonesterified FA
through FA binding proteins or transfer of phospholi-
pids from plasma lipoproteins. Some authors suggest
that there is an active protein-mediated transport of FA
into EM[30]. Furthermore, evidence exists that exchange
of FA in EM occurs as a lipid-mediated process via flip-
Figure 2 n-6 fatty acids (FA) in erythrocyte membranes in the three different dietary groups. Median and quartiles of the percentage of
n-6 FA in erythrocyte membranes in control (CONT), additive (ADD) and fish oil (FO) group at week 0, 1, 2, 4, 8, 12, 14 and 16 of experimental
feeding. Different uppercase letters indicate statistically significant differences between different time points within the individual groups.
Different Lowercase letters indicate statistically significant differences between groups at the same time point. (p ≤ 0.01). The FA included for the
calculation of total n-6 FA are listed in additional file 1.
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results suggest that FA transfer from plasma to erythro-
cytes plays a predominant role in determining EM FA
composition when dietary fat intake is changed. This
was also shown by Orton et al.[17]. We cannot exclude
the possibility that after prolonged periods of interven-
tion, a sustained increase in n-3 FA of erythrocytes may
occur during replacement of erythrocytes. Nevertheless,
it is improbable for erythrocyte turnover to make a
major contribution to the early changes in n-3 FA con-
tent of the EM observed in our study.
The increase of DHA in EM as calculated by its AUC
reached higher values in ADD than in FO (Figure 6).
The proportions of DHA and EPA in ADD are different
from those of FO. Consequently, we assume that DHA-
rich supplements have a greater ability to advance DHA
content in cell membranes than other fish oil based
PUFA diets rich in EPA. If future in-vivo studies con-
firm beneficial effects of DHA supplementation in dogs,
this fact may be advantageous in dietary support of dis-
orders or conditions in dogs, like cancer or in the
nutrition of the developing puppy, where DHA is found
to be more beneficial than EPA.
In the present study, DHA and not EPA was prefer-
ably incorporated into the EM. This fact agrees with
the study of Milte et al.[24], in which the increase of
human erythrocyte DHA was more pronounced than
that of EPA after consumption of a DHA-rich fish oil.
Our results conflict with the study of Brown et al.[12]
in which human erythrocyte EPA was strongly corre-
lated to the amount of EPA in the diet, while the
change in erythrocyte DHA was correlated with the
duration of the feeding period irrespective of the
amount of DHA. A preferential incorporation of EPA
was also observed in humans receiving a EPA-rich fish
oil diet[32]. Our data also contradict the results of
Jude et al.[33] in dogs. In this study a fish oil-enriched
diet containing twice as much DHA as EPA showed a
preferential incorporation of EPA. These conflicting
results might be due to previous dietary exposure to
FA[28] or to different FA sources, formulations, pro-
portions and concentrations.
Figure 3 Docosahexaenoic acid (DHA) in erythrocyte membranes in the three different dietary groups.M e d i a na n dq u a r t i l e so ft h e
percentage of DHA in erythrocyte membranes in control (CONT), additive (ADD) and fish oil (FO) group at week 0, 1, 2, 4, 8, 12, 14 and 16 of
experimental feeding. Different uppercase letters indicate statistically significant differences between different time points within the individual
groups. Different Lowercase letters indicate statistically significant differences between groups at the same time point. (p ≤ 0.01).
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were significantly lowered in ADD and FO compared
to baseline levels, but these values did not show signif-
icant differences to the n-6 FA in CONT until week 8.
The incorporation of n-3 FA at the expense of AA has
been shown earlier by Jude et al.[33] and Kew et al.
[26]. There was also a significant reduction of n-6 FA
in FO, despite the fact, that the daily uptake of n-6 FA
in this group (787.5 mg/d/kg body weight) was higher
than in ADD (533.4 mg/d/kg body weight). Although
the content of AA in FO is about three times higher
than in CONT and ADD (Table 2), an increase of ery-
throcyte AA in FO was not observed. It is possible
that the EM already reached their maximum AA con-
tent during the 8 weeks before the onset of the study,
when all animals got the CONT diet. This would mean
that, even though the FO diet has a higher AA content
than the CONT diet, no further increase of EM AA
content could be expected. Furthermore, the high EPA
content in the FO diet possibly reduced AA incorpora-
tion in EM. Despite FO and CONT having similar
dietary ratios of n-6 to n-3 FA (Table 1) and the diet-
ary n-6 to n-3 FA ratio of ADD being much smaller
than that of CONT or FO (3.75:1 vs 6.61:1 and 7.24:1)
the ratio of n-6 to n-3 FA content in EM at the end of
the study did not differ between ADD and FO. In a
study examining the influence of dietary n-3 FA on
canine plasma FA composition Hall et al. could show
that up to certain dietary concentrations the dose of n-
3 FA administered, independent of the n-6 to n-3 FA
ratio, determined the plasma n-3 FA composition[34].
O u rr e s u l t ss u g g e s tt h a tt h es a m ei st r u ef o rE M .H o w -
ever, in another study it was shown that alterations of
canine plasma FA composition appeared to depend on
both the dose of dietary n-3 FA and the n-6 to n-3
ratio[35]. Therefore, it might be possible that combin-
ing dietary n-3 PUFA with low levels of AA can be
even more effective in diminishing cellular AA than
increasing dietary n-3 FA alone. By diminishing cellu-
lar AA the release of inflammatory mediators can be
reduced and the health status of patients with chronic
inflammatory diseases could be improved[3,36]. Our
Figure 4 Eicosapentaenoic acid (EPA) in erythrocyte membranes in the three different dietary groups. Median and quartiles of the
percentage of EPA in erythrocyte membranes in control (CONT), additive (ADD) and fish oil (FO) group at week 0, 1, 2, 4, 8, 12, 14 and 16 of
experimental feeding. Different uppercase letters indicate statistically significant differences between different time points within the individual
groups. Different Lowercase letters indicate statistically significant differences between groups at the same time point. (p ≤ 0.01).
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of EPA and DHA in EM. These data are comparable
with earlier results of plasma and neutrophil FA in
dogs [37], supporting the concept of a competitive and
“saturable” hyperbolic relationship between dietary n-3
PUFA, plasma and tissue FA in dogs. The results of
the present study are to some extent consistent with
the findings that the equilibration of erythrocyte FA is
dependent on abundance and proportion of the differ-
ent FA in the diet. However, our data cannot exclude
that there are other factors such as previous dietary
exposure to n-6 FA and source or formulation of the
dietary lipids that might influence the equilibration
process of FA in cellular membranes. Since in contrast
to n-3 FA, n-6 FA were not equilibrated within the 12
w e e k so ft h eo b s e r v a t i o nt i m ei ti si m p o r t a n tt oc o n -
duct further studies in order to determine the equili-
bration time of n-6 FA. A slow equilibration process of
n-6 FA could also explain the fact that, in spite of the
rapid response of EM n-3 FA content, it takes a few
weeks to observe beneficial effects of dietary n-3 FA
supplementation in dogs[36,38].
The period after finishing n-3 FA supplementation in
ADD in the intent to observe re-establishment of base-
line levels was too short. Nevertheless, the increased
erythrocyte n-3 FA content significantly declined and n-
6 FA content significantly increased during this period.
These data indicate that for studies dealing with dietary
n - 3F Ai nd o g saw a s h o u tp e r i o do f>4w e e k si s
required. According to Brown et al.[12], for EPA it takes
18 weeks to return to baseline levels in dogs, whereas
DHA has an extended washout period (> 18 weeks).
Although there are many studies on the incorporation
of FA into cell membranes, the factors which influence
FA inclusion, except for FA concentration in test meals,
remain unclear. More research on the time course of
incorporation of PUFA into EM and other cell mem-
branes is needed to clarify whether it depends on the
concentration, the formulation of these lipids or if there
are species specific effects.
Figure 5 Arachidonic acid (AA) in erythrocyte membranes in the three different dietary groups. Median and quartiles of the percentage
of AA in erythrocyte membranes in control (CONT), additive (ADD) and fish oil (FO) group at week 0, 1, 2, 4, 8, 12, 14 and 16 of experimental
feeding. Different uppercase letters indicate statistically significant differences between different time points within the individual groups.
Different Lowercase letters indicate statistically significant differences between groups at the same time point. (p ≤ 0.01).
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Moderate n-3 PUFA intake in dogs leads to incorporation
of DHA and EPA in erythrocytes in a dose-dependent
manner. Significant changes of membrane total n-3 FA,
EPA and DHA were observable from the first week of the
study. The content of these FA in EM reached a plateau
no later than eight weeks. In contrast, total n-6 FA and
AA were not equilibrated after 12 weeks, suggesting that
the decrease of n-6 FA membrane content in reaction to
dietary changes might be delayed. In our study, the addi-
tive combined with a dry dog food diet containing no EPA
or DHA was as effective in increasing total n-3 FA as
changing the diet to a dry dog food diet with a high EPA
and DHA content. These findings indicate that it might be
possible to supplement an existing diet with an n-3 fatty
acid additive instead of completely changing the diet. For
dogs with dietary intolerance, this is a substantial improve-
ment. Further studies are needed to determine whether
increasing dietary n-3 FA is as effective and leads to the
same rapid increase of EM n-3 FA content in diseased
dogs as in the healthy dogs used in our study.
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